Endocrine Society Calls for Solutions Regarding Insulin Price Crisis

The Endocrine Society lauds Novo Nordisk’s recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue.

People with type 1 diabetes are unable to produce their own insulin and need insulin treatment to maintain their glucose control. People with the more common type 2 diabetes do not produce enough insulin and may need insulin treatment as well. Many people with diabetes depend on insulin, yet increasing prices creates a dangerous barrier to access this critical therapy.

The Society strongly advocates for people with diabetes who depend on insulin to treat their disease to have affordable access to this life-saving therapy. The Society will work with all stakeholders to determine both the cause of increasing prices as well as additional ways to ensure access to insulin.

The Society believes that with greater transparency across the insulin supply chain, stakeholders can work together to make drug pricing more predictable, reduce out-of-pocket costs, and help patients and providers have access to affordable, patient-centered therapies.

You may also like

  • Obamacare Repeal Expected to Come First in New Congress

    Senate Majority Leader Mitch McConnell (R-KY) has announced that a resolution to allow for the replacement of the healthcare law would be the first item of business for the Senate in the next Congress, starting Jan. 3. It is expected that to dismantle the law, Congress will use a budget process, known as reconciliation, that…

  • Photos: Hill Briefing – 25 Years of Research on EDCs

    On Wednesday September 21, the Dirksen Senate Office Building in Washington D.C., was set upon by Endocrine Society members, staff, members of congressional offices, the media, and other interested parties to learn more about endocrine-disrupting chemicals (EDCs) and the threats they pose to human health. The seminar, “From Hormones to Brain Development: 25 Years of…

Find more in